Hospital admissions for HIV-infected prisoners in Italy
Published date | 12 June 2017 |
Pages | 105-112 |
Date | 12 June 2017 |
DOI | https://doi.org/10.1108/IJPH-02-2016-0004 |
Author | Emanuele Pontali,Roberto Ranieri,Elena Rastrelli,Maria Donata Iannece,Anna Maria Ialungo,Serena Dell’Isola,Alfonso Liberti,Pietro Rosario,Rodolfo Casati,Giulio Starnini,Sergio Babudieri |
Subject Matter | Health & social care,Criminology & forensic psychology,Prisoner health,Sociology,Sociology of crime & law,Public policy & environmental management,Policing,Criminal justice |
Hospital admissions for HIV-infected
prisoners in Italy
Emanuele Pontali, Roberto Ranieri, Elena Rastrelli, Maria Donata Iannece,
Anna Maria Ialungo, Serena Dell’Isola, Alfonso Liberti, Pietro Rosario, Rodolfo Casati,
Giulio Starnini and Sergio Babudieri
Abstract
Purpose –The purpose of this paper is to give a description of the clinical conditions and patient
demographics of inpatient admissions of human immunodeficiency virus (HIV)-infected inmates in three
hospital wards that provide hospital care for inmates in Italy.
Design/methodology/approach –This is a retrospective review of hospital medical admissions of
patients living with HIV from January 1 to December 31, 2014, in three Italian referral centers for
hospitalization of inmates.
Findings –A total of 85 admissions for 85 different HIV-infected inmates occurred in 2014 in the three
centers participating to the study. Most patients (54.1 percent) were co-infected with hepatitis C. Discharge
diagnosis largely varied ranging from common HIV-related co-morbidities to completely independent
diagnosis. The most commonly observed discharge diagnoses were chronic hepatitis C, liver cirrhosis,
opiate dependence and thrombocytopenia.
Originality/value –Discharge diagnosis between HIV-infected inmates and HIV-infected patients in freedom
are strikingly and significantly different. A large number of hospitalized HIV-infected inmates were affected by
chronic viral hepatitis and liver cirrhosis; this is probably a direct consequence of the high prevalence of HCV
and/or HBV co-infections in the inmate population in Italy. In addition, a significantly lower proportion of
cancer diagnosis was observed among inmates; this is possibly justified by the fact that in our Italian settings
when HIV infection is at advanced stages or if cancer treatment is started those affected are released from
prison and can continue their diagnostic and treatment follow-up in freedom.
Keywords HIV, HIV/AIDS, Prisoners, Mental illness, Drug dependence, HCV
Paper type Research paper
Introduction
Since its introduction, combination antiretroviral treatment has resultedin a decline in opportunistic
infections rates and has significantly reduced human immunodeficiency virus (HIV)-associated
morbidity andmortality (Floridia et al., 2002; Mocroftet al., 2004; Palella et al., 1998).Yet, mortality
rates among HIV-infected subjects remain 3 to 15 timeshigher than those observed in thegeneral
population (Antiretroviral Therapy Cohort Collaboration et al., 2009; Cockerham et al.,2010).
In fact, non-infectious and non-HIV-related co-morbidities appear to be more frequent as the
HIV-infected population starts to age (Aguiar et al., 2015; Justice, 2006; Magoni et al.,2011;
Phillips etal., 2008; Sackoff et al., 2006; Weberet al., 2006). In addition, this aging populationmay
also have earlier presentation of such co-morbidities as reported by several authors (Althoff et al.,
2014; Guaraldi et al., 2011; Schouten et al., 2014).
There are studies reporting premature age-related co-morbidities and higher hospitalization
rates amongst patients living with HIV compared to the general population (Falster et al., 2010;
Guaraldi et al., 2011; Magoni et al., 2011). The future impact of such clinical manifestations on
patient care and service provision is still unfolding and information on current trends may be
helpful in planning future services.
Received 23 February 2016
Revised 5 June 2016
30 September 2016
Accepted 3 October 2016
The authors affiliations can be
found at the end of this article.
DOI 10.1108/IJPH-02-2016-0004 VOL. 13 NO. 2 2017, pp. 105-112, © Emerald Publishing Limited, ISSN 1744-9200
j
INTERNATIONALJOURNAL OF PRISONER HEALTH
j
PAG E 10 5
To continue reading
Request your trial